Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 734

1.

Stroke and apolipoprotein E epsilon4 are independent risk factors for cognitive decline: A population-based study.

Dik MG, Deeg DJ, Bouter LM, Corder EH, Kok A, Jonker C.

Stroke. 2000 Oct;31(10):2431-6.

2.

Memory complaints and APOE-epsilon4 accelerate cognitive decline in cognitively normal elderly.

Dik MG, Jonker C, Comijs HC, Bouter LM, Twisk JW, van Kamp GJ, Deeg DJ.

Neurology. 2001 Dec 26;57(12):2217-22.

PMID:
11756600
3.

APOE-epsilon4 is associated with memory decline in cognitively impaired elderly.

Dik MG, Jonker C, Bouter LM, Geerlings MI, van Kamp GJ, Deeg DJ.

Neurology. 2000 Apr 11;54(7):1492-7.

PMID:
10751265
4.

Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study.

Knopman DS, Mosley TH, Catellier DJ, Coker LH; Atherosclerosis Risk in Communities Study Brain MRI Study.

Alzheimers Dement. 2009 May;5(3):207-14. doi: 10.1016/j.jalz.2009.01.027. Epub 2009 Apr 11.

PMID:
19362884
5.

The role of APOE-epsilon4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging.

Bretsky P, Guralnik JM, Launer L, Albert M, Seeman TE; MacArthur Studies of Successful Aging.

Neurology. 2003 Apr 8;60(7):1077-81.

PMID:
12682309
6.

Association between ApoE epsilon4 and cognitive impairment after stroke.

Wagle J, Farner L, Flekkøy K, Wyller TB, Sandvik L, Eiklid KL, Fure B, Stensrød B, Engedal K.

Dement Geriatr Cogn Disord. 2009;27(6):525-33. doi: 10.1159/000223230. Epub 2009 Jun 4.

PMID:
19494491
7.

APOE epsilon4 and cognitive decline in older stroke patients with early cognitive impairment.

Ballard CG, Morris CM, Rao H, O'Brien JT, Barber R, Stephens S, Rowan E, Gibson A, Kalaria RN, Kenny RA.

Neurology. 2004 Oct 26;63(8):1399-402.

PMID:
15505155
8.

Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.

Devanand DP, Pelton GH, Zamora D, Liu X, Tabert MH, Goodkind M, Scarmeas N, Braun I, Stern Y, Mayeux R.

Arch Neurol. 2005 Jun;62(6):975-80.

PMID:
15956169
9.

The joint effect of apolipoprotein E epsilon4 and MRI findings on lower-extremity function and decline in cognitive function.

Carmelli D, DeCarli C, Swan GE, Kelly-Hayes M, Wolf PA, Reed T, Guralnik JM.

J Gerontol A Biol Sci Med Sci. 2000 Feb;55(2):M103-9.

PMID:
10737693
10.

Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.

Caselli RJ, Reiman EM, Locke DE, Hutton ML, Hentz JG, Hoffman-Snyder C, Woodruff BK, Alexander GE, Osborne D.

Arch Neurol. 2007 Sep;64(9):1306-11.

PMID:
17846270
11.

The APOE epsilon4 allele is associated with decline on delayed recall performance in community-dwelling older adults.

O'Hara R, Yesavage JA, Kraemer HC, Mauricio M, Friedman LF, Murphy GM Jr.

J Am Geriatr Soc. 1998 Dec;46(12):1493-8.

PMID:
9848808
12.

Apolipoprotein E genotype and lifetime cognitive decline.

Kozauer NA, Mielke MM, Chan GK, Rebok GW, Lyketsos CG.

Int Psychogeriatr. 2008 Feb;20(1):109-23. Epub 2007 Aug 22.

PMID:
17711604
13.

Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.

Hoyt BD, Massman PJ, Schatschneider C, Cooke N, Doody RS.

Arch Neurol. 2005 Mar;62(3):454-9.

PMID:
15767511
14.

Albumin, apolipoprotein E-epsilon4 and cognitive decline in community-dwelling Chinese older adults.

Ng TP, Niti M, Feng L, Kua EH, Yap KB.

J Am Geriatr Soc. 2009 Jan;57(1):101-6. doi: 10.1111/j.1532-5415.2008.02086.x. Epub 2008 Nov 19.

PMID:
19054180
15.

APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging.

Bunce D, Fratiglioni L, Small BJ, Winblad B, Bäckman L.

Neurology. 2004 Sep 14;63(5):816-21.

PMID:
15365129
16.

Midlife cardiovascular risk factors, ApoE, and cognitive decline in elderly male twins.

Carmelli D, Swan GE, Reed T, Miller B, Wolf PA, Jarvik GP, Schellenberg GD.

Neurology. 1998 Jun;50(6):1580-5.

PMID:
9633697
17.

Association between apolipoprotein E ε4 and longitudinal cognitive decline: nested case-control study among chinese community-dwelling elders.

Ma F, Wang J, Miao R, Zhao W, Wang Q.

Neuropsychobiology. 2011;64(2):102-9. doi: 10.1159/000324991. Epub 2011 Jun 21.

PMID:
21701228
18.

Impact of APOE status on cognitive maintenance in healthy elderly persons.

Zehnder AE, Bläsi S, Berres M, Monsch AU, Stähelin HB, Spiegel R.

Int J Geriatr Psychiatry. 2009 Feb;24(2):132-41. doi: 10.1002/gps.2080.

PMID:
18615849
19.

Serum inflammatory proteins and cognitive decline in older persons.

Dik MG, Jonker C, Hack CE, Smit JH, Comijs HC, Eikelenboom P.

Neurology. 2005 Apr 26;64(8):1371-7.

PMID:
15851726
20.
Items per page

Supplemental Content

Write to the Help Desk